Gomal Journal of Medical Sciences
LIPID PROFILE IN TYPE 2 DIABETICS VERSUS NON-DIABETIC CONTROLS IN ADULT POPULATION OF DISTRICT BANNU, PAKISTAN
Abstract
Background: High cholesterol, triglyceride and LDL and low HDL are high risk factors in type 2 diabetics in giving rise to cardiovascular diseases. The objectives of this study were to compare the serum concentrations (mg/dL) of cholesterol, TG, HDL and LDL in type 2 diabetics versus non-diabetic controls in adult population of district Bannu, Pakistan.
Materials & Methods: This comparative cross-sectional study was conducted in Department of Pathology, Bannu Medical College, Bannu, Pakistan from March, 2020 to February, 2021. Total known 100 type 2 diabetics along with 50 non-diabetic controls of >35 years age were selected. Those with acute myocardial infarction, acute cerebrovascular accident, chronic renal failure, acute burns, trauma, post-surgery, pregnant women and those taking lipid/ blood pressure lowering drugs were excluded. Socio-demographic variables were age in years, sex, occupation, residence and family income/month in PKR. Serum cholesterol, triglycerides, HDL and LDL were four research variables on ratio scale and were analyzed by mean, SD and range with 95% CI. Independent samples t-test was used to compare the variables between the two groups.
Results: The study group included 100 type 2 diabetics (66 men and 34 women) and 50 (29 men and 21 women) controls. Mean cholesterol concentration (mg/dL) was significantly higher (p=<.0001) in diabetics (208.22±55.24) than controls (150.26±25.29). Mean triglycerides concentration (mg/dL) was significantly higher (p=<.0001) in diabetics (202.58±82.62) than controls (157.88±53.42). Mean LDL concentration (mg/dL) was significantly higher (p=<.0001) in diabetics (148.11±55.06) than controls (113.22±32.97). Mean HDL concentration (mg/dL) was significantly lower (p=.002) in diabetics (42.48±14.24) than controls (49.38±11.76).
Conclusion: The current study concludes that serum concentrations of cholesterol, triglyceride and LDL were significantly higher in type 2 diabetics than controls, while HDL was lower in diabetics than controls. High cholesterol, TG and LDL along with low HDL are high risk factors in type 2 diabetics in giving rise to cardiovascular diseases; that needs evaluation at earlier stages.
Keywords
Full Text:
PDFReferences
Rossi G, American Diabetes Association. Diagnosis and classification of diabetes mellitus. Recenti Prog Med 2010; 101(7-8):274-6. https://doi.org/10.1210/jcem.84.4.5612
Mahler RJ, Adler ML. Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. J Clin Endocrinol Metab 1999 Apr; 84(4):1165-71. https://doi.org/10.1210/jcem.84.4.5612
Roglic G. WHO Global report on diabetes: A summary. Int J Noncommun Dis 2016; 1:3-8. https://doi.org/10.4103/2468-8827.184853
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health 2020 Mar;10(1):107-11. https://doi.org/10.2991/jegh.k.191028.001
Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in Shikarpur, Sindh Province. Diabet Med 1995 Dec; 12(12):1116-21. https://doi.org/10.1111/j.1464-5491.1995.tb00430.x
Shera AS, Rafique G, Khwaja IA, Baqai S, Khan IA, King H. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in North West Frontier Province (NWFP) of Pakistan. J Pak Med Assoc 1999 Sep; 49(9):206-11. https://doi.org/10.1016/S0168-8227(99)00017-0
Shera AS, Basit A, Fawwad A, Hakeem R, Ahmedani MY, Hydrie MZ, et al. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in the Punjab Province of Pakistan. Prim Care Diabetes 2010 Jul;4(2):79-83. https://doi.org/10.1016/j.pcd.2010.01.003
Yar HM, Shabbir K, Anwar M, Ali R. Diabetes mellitus; frequency among general population of Rahim Yar Khan. Professional Med J Jun 2008;15(2):240-6. https://doi.org/10.29309/TPMJ/2008.15.02.2767
Meo SA, Zia I, Bukhari IA, Arain SA. Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. J Pak Med Assoc 2016 Dec; 66(12):1637-42.
Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. BMJ Open 2018 Aug 1;8(8):e020961. https://doi.org/10.1136/bmjopen-2017-020961
Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens 2013;2013:653789. https://doi.org/10.1155/2013/653789
Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998 Mar 14;316 (7134):823-8. https://doi.org/10.1136/bmj.316.7134.823
Haffner SM; American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004 Jan;27 Suppl 1:S68-71. https://doi.org/10.2337/diacare.27.2007.S68
Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, et al. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 2004 Sep 1;114(5):659-68. https://doi.org/10.1172/JCI200417867
Pakistan Bureau of Statistics. Final Results (Census-2017). Salient Features - 6th Population & Housing Census 2017. Contents (District Tables). Khyber Pakhtunkhwa [cited 2020 Mar 12]. Available at: https://www.pbs.gov.pk/content/final-results-census-2017
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974 Apr;20(4):470-5. https://doi.org/10.1093/clinchem/20.4.470
McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983 Mar;29(3):538-42. https://doi.org/10.1093/clinchem/29.3.538
Trinder P, Webster D. Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem 1984 Sep; 21 (Pt 5):430-3. https://doi.org/10.1177/000456328402100516
Idogun ES, Unuigbe EI, Ogunro PS, Akinola OT, Famodu AA. Assessment of serum lipids in Nigerians with type 2 diabetes mellitus complications. Pak J Med Sci 2007 Oct-Dec (Part-I);23(5):708-12.
Al-Nuaim AR, Famuyiwa O, Greer W. Hyperlipidemia among Saudi diabetic patients-pattern and clinical characteristics. Ann Saudi Med 1995 May;15(3):240-3. https://doi.org/10.5144/0256-4947.1995.240
Akbar D. Metabolic syndrome is common in Saudi type 2 diabetic patients. Hypertension 2002;12(2):47-9.
Uttra KM, Devrajani BR, Shah SZ, Devrajani T, Das T, Raza S, et al. Lipid profile of patients with diabetes mellitus (A multidisciplinary study). World Appl Sci J 2011;12(9):1382-4.
Syvänne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997 Jul 1;350:S20-3. https://doi.org/10.1016/S0140-6736(97)90024-6
Dallinga-Thie GM, van Tol A, Hattori H, Van Vark-van der Zee LC, Jansen H, Sijbrands EJ. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. Diabetologia 2006 Jul;49(7):1505-11. https://doi.org/10.1007/s00125-006-0261-0
Nakhjavani M, Esteghamati AR, Heshmat FE. Dyslipidemia in type 2 diabetes mellitus: more atherogenic lipid profile in women. Acta Med Iran 2006:111-8.
Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 1989 May;32(5):300-4. https://doi.org/10.1007/BF00265546
Bhatti SM, Dhakam S, Khan MA. Trends of lipid abnormalities in Pakistani type-2 diabetes mellitus patients: A tertiary care centre data. Pak J Med Sci 2009 Oct 1; 25(6):883-9.
Firdous S, Zafarullah M. Comparison of patterns of lipid profile in type-2 diabetics and non-diabetics. Ann King Edward Med Coll 2007;13(1):84-7.
Khan SR, Ayub N. Triglyceride profile in dyslipidemia of type 2 diabetes mellitus. J Coll Physicians Surg Pak 2008;18(5):270-3.
Boren J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2020 Jun 21;41(24):2313-30. https://doi.org/10.1093/eurheartj/ehz962
Biadgo B, Abebe SM, Baynes HW, et al. Correlation between serum lipid profile with anthropometric and clinical variables in patients with type 2 diabetes mellitus. Ethiop J Health Sci 2017 May;27(3):215-26. https://doi.org/10.4314/ejhs.v27i3.3
Márk L, Dani G. [Diabetic dyslipidaemia and the atherosclerosis]. Orv Hetil 2016 May;157(19):746-52. https://doi.org/10.1556/650.2016.30441
Gonna H, Ray KK. The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes. Diabetes Obes Metab 2019 Apr;21 Suppl 1:6-16. https://doi.org/10.1111/dom.13691
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Rev Endocrinol 2009 Mar; 5(3):150-9. https://doi.org/10.1038/ncpendmet1066
Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs 2013 Mar;73(4):327-39. https://doi.org/10.1007/s40265-013-0023-5
Singh G, Kumar AK. A study of lipid profile in type 2 diabetic Punjabi population. J Exerc Sci Phy 2012 Jun; 8(1):7-10. https://doi.org/10.18376//2012/v8i1/67599
Kontush A, Chapman MJ. Why is HDL functionally deficient in type 2 diabetes? Curr Diab Rep 2008 Feb;8(1):51-9. https://doi.org/10.1007/s11892-008-0010-5
Xepapadaki E, Nikdima I, Sagiadinou EC, Zvintzou E, Kypreos KE. HDL and type 2 diabetes: the chicken or the egg? Diabetologia 2021 Sep;64(9):1917-26. https://doi.org/10.1007/s00125-021-05509-0
Shahwan MJ, Jairoun AA, Farajallah A, Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes Metab Syndr 2019 Jul-Aug;13(4):2387-92. https://doi.org/10.1016/j.dsx.2019.06.009
Stamouli M, Pouliakis A, Mourtzikou A, Skliris A, Panagiotou I, Mournianakis E, et al. Evaluation of the lipid profile in type 2 diabetes mellitus patients in Greece. Clin Lab 2014;60(10):1593-1600. https://doi.org/10.7754/Clin.Lab.2013.130919
Rahmoun MN, Ghembaza CE, Ghembaza ME. Lipid profile in type 2 patients with diabetes from Tlemcen: A Western Algerian population. Diabetes Metabol Syndr: Clin Res Reviews 2019 Mar 1;13(2):1347-51. https://doi.org/10.1016/j.dsx.2019.02.008
Cui R, Qi Z, Zhou L, Li Z, Li Q, Zhang J, et al. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus. Clin Interv Aging 2016 Apr 18;11:445-52. https://doi.org/10.2147/CIA.S104803
Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag 2019;15:149-57. https://doi.org/10.2147/VHRM.S209830
Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis 2014 Dec;13:183. https://doi.org/10.1186/1476-511X-13-183
DOI: https://doi.org/10.46903/gjms/20.01.1015
Refbacks
- There are currently no refbacks.
Copyright (c) 2022. Hafiz Ullah Khan, ilyas Khan, Arif Ullah, Atif Ahmad Khan, Asrar Ur Rahman, Zarak Khan, Rahmat Ullah Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
JOURNAL INDEXING
